Tian Wu

671 citations
19 papers · 506 indexed · h-index 11
Topics
Cell Adhesion Molecules Research (5 papers)Atherosclerosis and Cardiovascular Diseases (3 papers)MicroRNA in disease regulation (2 papers)
Partner nations
China

In The Last Decade

Tian Wu

18 papers receiving 500 citations

Peers

Tian Wu
Comparison fields: 5 of 69
  • Endocrinology, Diabetes and Metabolism 160
  • Molecular Biology 116
  • Cancer Research 92
  • Immunology 90
  • Surgery 88
Replace Yu Meng with:
Yu Meng China
Feng Peng China
Zhaohui Wang China
El Houari Laghmani Netherlands
Takehiro Sejima Japan
Kenji Ashida Japan
Min Cheol Lee South Korea
Yuya Tsurutani Japan
Joshua Yang United States
I. Prieto Spain
Tian Wu relative to Yu Meng China Yu Meng's profile →
Citations per field
00.5×6.7×
Yu Meng · 1×
Citations per year

Countries citing papers authored by Tian Wu

Since Specialization
Citations

This map shows the geographic impact of Tian Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tian Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tian Wu more than expected).

Fields of papers citing papers by Tian Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tian Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tian Wu. The network helps show where Tian Wu may publish in the future.

Co-authorship network of co-authors of Tian Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Tian Wu. A scholar is included among the top collaborators of Tian Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tian Wu. Tian Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 0
2 2
3 4
4 5
5 17
6 10
7 8
8 1
9
miR-590-3p mediates the protective effect of curcumin on injured endothelial cells induced by angiotensin II.
11
10 53
11 33
12 2
13 46
14 62
15 30
16 66
17 3
18
Graves' disease and thyroid cancer.
74
19
Hürthle cell tumors: a twenty-five-year experience.
79

About Tian Wu

Tian Wu is a scholar working on Immunology and Allergy, Internal Medicine and Cancer Research, having authored 19 papers that have together received 506 indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (5 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (160 citations), Cancer Research (92 citations) and Psychiatry and Mental health (71 citations). Tian Wu has collaborated with scholars based in China. Frequent co-authors include Ren Guo, Bikui Zhang, E L Kaplan, M Arganini, Maureen McCormick, Francis H. Straus, Leslie J. DeGroot, Heng Yang, Xin Guo and Min Chen. Their work appears in journals such as PLoS ONE, Scientific Reports and BioMed Research International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026